Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY8.88
+0.48 (+5.71%)
CN SHZ Healthcare Medical - Care Facilities
Address
New Century Mansion No. 198 410015
Changsha, CN
Changsha, CN
CEO
Bang Chen
Website
aierchina.com
IPO
2009-10-30
ISIN CNE100000GR6
Description
Aier Eye Hospital Group Co., Ltd. is a prominent provider of ophthalmic healthcare services and institutions. Its comprehensive medical offerings encompass specialties such as the diagnosis and treatment of fundus diseases, optometry, refractive correction, glaucoma, corneal conditions, and cataracts. Beyond direct patient care, the company also conducts training courses focused on cataract prevention and management. The group boasts an extensive international footprint, operating approximately 500 ophthalmic facilities across mainland China, with additional presences including 86 in Europe, 1 in the United States, 7 in Hong Kong, and 12 throughout Southeast Asia. Founded in 2007, Aier Eye Hospital Group maintains its headquarters in Changsha, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY8.88
+0.48 (+5.71%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
95M
Beta
0.44
Float Shares
4.13B
Free Float %
44.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.19% | -0.65% | -15.40% | -13.96% | -20.70% | -16.94% | -26.51% | -56.38% | -76.19% | +138.12% | +953.31% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
8.88
DCF (Unlevered)
17.45
+96.5%
DCF (Levered)
14.95
+68.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
83% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 12 | +1 |
| Hold | 1 | -2 |
| Sell | 2 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
5.80
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+6.5% Q1'26: +6.1% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-7.9% Q1'26: +18.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+15.1% ★ Q1'26: +22.1% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+21.0% ★ Q1'26: +25.5% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+15.0% ★ Q1'26: +21.4% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.3% Q1'26: +0.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.17× ★ Q1'26: 1.12× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 13 Rev. Ana. 9 EPS Ana. |
Dec 2027 17 Rev. Ana. 9 EPS Ana. |
Dec 2028 11 Rev. Ana. 11 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.17B
est: 3.09B (+2.5%)
|
4.00B
est: 4.05B (-1.2%)
|
5.96B
est: 5.70B (+4.6%)
|
8.01B
est: 8.09B (-1.0%)
|
9.99B
est: 10.17B (-1.8%)
|
11.91B
est: 11.66B (+2.1%)
|
15.00B
est: 15.17B (-1.1%)
|
16.11B
est: 17.49B (-7.9%)
|
20.37B
est: 20.66B (-1.4%)
|
20.98B
est: 20.99B (0.0%)
|
22.35B
est: 22.51B (-0.7%)
|
24.47B
23.99B – 24.82B
+8.7% YoY
|
26.91B
24.73B – 28.47B
+10.0% YoY
|
29.35B
29.32B – 29.38B
+9.1% YoY
|
| EBITDA |
709.55M
est: 885.52M (-19.9%)
|
827.22M
est: 1.16B (-28.7%)
|
1.29B
est: 1.64B (-21.2%)
|
1.94B
est: 2.32B (-16.2%)
|
2.68B
est: 2.92B (-8.1%)
|
3.72B
est: 3.35B (+11.1%)
|
4.51B
est: 4.35B (+3.7%)
|
4.51B
est: 5.02B (-10.2%)
|
5.91B
est: 5.83B (+1.3%)
|
5.28B
est: 5.93B (-11.0%)
|
6.47B
est: 6.36B (+1.8%)
|
6.91B
6.77B – 7.01B
+8.7% YoY
|
7.60B
6.98B – 8.04B
+10.0% YoY
|
8.29B
8.28B – 8.30B
+9.1% YoY
|
| EBIT |
586.65M
est: 775.07M (-24.3%)
|
684.04M
est: 1.02B (-32.7%)
|
1.09B
est: 1.43B (-23.8%)
|
1.68B
est: 2.03B (-17.2%)
|
2.33B
est: 2.55B (-8.8%)
|
3.30B
est: 2.93B (+12.8%)
|
4.02B
est: 3.81B (+5.6%)
|
3.89B
est: 4.39B (-11.5%)
|
5.22B
est: 4.91B (+6.4%)
|
4.46B
est: 4.99B (-10.7%)
|
4.69B
est: 5.35B (-12.3%)
|
5.81B
5.70B – 5.90B
+8.7% YoY
|
6.39B
5.88B – 6.77B
+10.0% YoY
|
6.97B
6.97B – 6.98B
+9.1% YoY
|
| Net Income |
428.04M
est: 480.88M (-11.0%)
|
556.99M
est: 641.62M (-13.2%)
|
742.51M
est: 807.94M (-8.1%)
|
1.01B
est: 1.09B (-7.1%)
|
1.38B
est: 1.44B (-4.3%)
|
1.72B
est: 1.79B (-3.5%)
|
2.32B
est: 2.40B (-3.0%)
|
2.52B
est: 2.89B (-12.6%)
|
3.36B
est: 3.70B (-9.1%)
|
3.56B
est: 3.56B (0.0%)
|
3.24B
est: 3.37B (-3.9%)
|
3.78B
3.72B – 3.85B
+12.3% YoY
|
4.36B
3.77B – 4.62B
+15.2% YoY
|
5.02B
4.36B – 5.63B
+15.0% YoY
|
| SGA |
854.31M
est: 708.58M (+20.6%)
|
1.11B
est: 929.02M (+19.5%)
|
1.56B
est: 1.31B (+19.0%)
|
1.85B
est: 1.86B (-0.2%)
|
2.31B
est: 2.33B (-1.3%)
|
2.49B
est: 2.68B (-6.9%)
|
3.40B
est: 3.48B (-2.2%)
|
3.85B
est: 4.02B (-4.1%)
|
4.64B
est: 4.26B (+8.8%)
|
5.14B
est: 4.33B (+18.8%)
|
2.07B
est: 4.64B (-55.5%)
|
5.04B
4.95B – 5.12B
+8.7% YoY
|
5.55B
5.10B – 5.87B
+10.0% YoY
|
6.05B
6.04B – 6.06B
+9.1% YoY
|
| EPS |
0.05
est: 0.05 (+1.5%)
|
0.07
est: 0.07 (-4.2%)
|
0.09
est: 0.09 (-0.1%)
|
0.12
est: 0.12 (+2.1%)
|
0.16
est: 0.16 (+2.6%)
|
0.19
est: 0.19 (-1.7%)
|
0.26
est: 0.26 (+0.3%)
|
0.28
est: 0.31 (-10.4%)
|
0.36
est: 0.40 (-10.8%)
|
0.38
est: 0.39 (-3.3%)
|
0.35
est: 0.39 (-9.5%)
|
0.41
0.40 – 0.42
+5.6% YoY
|
0.47
0.41 – 0.50
+14.3% YoY
|
0.53
0.47 – 0.61
+13.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
4.34B
OE per share TTM
0.47
Owner's Yield
5.11%
Maintenance CapEx ratio
13.22%
Maint CapEx / Avg PPE
45.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 140 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | KraneShares MSCI All China Health Care Index ETF KURE | 1.96% | 1.56M | 0.79% |
| 2 | VanEck ChiNext ETF CNXT | 0.56% | 675.0K | 0.65% |
| 3 | HSBC MSCI China A UCITS ETF HMCT.L | 0.30% | 409.9K | 0.30% |
| 4 | Xtrackers Harvest CSI 300 China A-Shares ETF ASHR | 0.16% | 2.23M | 0.65% |
| 5 | Xtrackers Harvest CSI300 UCITS ETF 1D ASHR.L | 0.16% | 499.6K | 0.65% |
| 6 | Samsung KODEX China CSI300 ETF 283580.KS | 0.16% | 314.4K | 0.12% |
| 7 | Xtrackers MSCI China A UCITS ETF 1C XX2D.L | 0.15% | 209.3K | 0.35% |
| 8 | Amundi MSCI China A UCITS ETF Acc CNAA.L | 0.15% | 214.6K | 0.35% |
| 9 | iShares MSCI China A UCITS ETF CNYA.L | 0.15% | 4.63M | 0.40% |
| 10 | iShares MSCI China A UCITS ETF CNYE.MI | 0.15% | 152.6K | 0.45% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
110.0K
Shares Outstanding
9.27B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Aiming Li | Deputy General Manager | — | male |
| Bang Chen | Founder & Chairman of the Board | — | male |
| Duoyuan Liu | Deputy General Manager | — | male |
| Jun Feng | Deputy General Manager | — | female |
| Li Hua Wang | Deputy General Manager | — | female |
| Li Jinzhou | Director of Investor Relations | — | — |
| Li Li | Vice Chairman & GM | — | male |
| Lihua Wang | Deputy General Manager | — | female |
| Lin Zhao | Accounting Supervisor | — | — |
| Qiwen Mo | Chief Financial Officer | — | female |
| Shi Jun Wu | Deputy GM, Secretary of the Board of Directors & Director | — | male |
| Shibo Tang | Deputy General Manager | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300015.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
